2Seventy Bio Inc (TSVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 92,356 | 71,244 | 59,984 | 111,864 | 56,792 |
| Marketable Securities | 78,019 | 103,510 | 132,415 | 90,009 | 124,590 |
| Receivables | 23,928 | 7,781 | 22,275 | 18,125 | 11,977 |
| Other current assets | 0 | 0 | 0 | 0 | 12,786 |
| TOTAL | $198,582 | $187,256 | $218,479 | $224,871 | $212,842 |
| Non-Current Assets | |||||
| PPE Net | 32,299 | 33,759 | 35,237 | 36,719 | 38,234 |
| Investments And Advances | 2,987 | 8,867 | 0 | 0 | 0 |
| Intangibles | 5,708 | 5,885 | 6,063 | 6,240 | 6,417 |
| Other Non-Current Assets | 240,429 | 243,743 | 244,067 | 250,066 | 253,558 |
| TOTAL | $281,423 | $292,254 | $285,367 | $293,025 | $298,209 |
| Total Assets | $480,005 | $479,510 | $503,846 | $517,896 | $511,051 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,176 | 1,055 | 5,076 | 2,995 | 8,801 |
| Accrued Expenses | 19,460 | 22,672 | 23,222 | 28,702 | 22,263 |
| TOTAL | $41,397 | $40,092 | $44,095 | $47,204 | $60,406 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 16,336 |
| Other Non-Current Liabilities | 224,647 | 228,612 | 231,649 | 235,888 | 240,756 |
| TOTAL | $224,647 | $228,612 | $231,649 | $235,888 | $243,206 |
| Total Liabilities | $266,044 | $268,704 | $275,744 | $283,092 | $303,612 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,230 | 52,338 | 51,588 | 51,498 | 51,405 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -567,982 | -568,464 | -548,944 | -539,011 | -563,890 |
| Other shareholders' equity | 54 | 89 | 305 | -236 | -336 |
| TOTAL | $213,961 | $210,806 | $228,102 | $234,804 | $207,439 |
| Total Liabilities And Equity | $480,005 | $479,510 | $503,846 | $517,896 | $511,051 |